Skip to Main Content
Back to News

CO-DIAGNOSTIC Earnings Results: $CODX Reports Quarterly Earnings

None

CO-DIAGNOSTIC ($CODX) posted quarterly earnings results on Thursday, August 14th. The company reported earnings of -$0.23 per share, beating estimates of -$0.63 by $0.40. The company also reported revenue of $160,000, beating estimates of $153,000 by $7,000.

You can see Quiver Quantitative's $CODX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

CO-DIAGNOSTIC Hedge Fund Activity

We have seen 12 institutional investors add shares of CO-DIAGNOSTIC stock to their portfolio, and 18 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CO-DIAGNOSTIC Analyst Ratings

Wall Street analysts have issued reports on $CODX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • D. Boral Capital issued a "Buy" rating on 04/28/2025

To track analyst ratings and price targets for CO-DIAGNOSTIC, check out Quiver Quantitative's $CODX forecast page.

CO-DIAGNOSTIC Price Targets

Multiple analysts have issued price targets for $CODX recently. We have seen 2 analysts offer price targets for $CODX in the last 6 months, with a median target of $5.5.

Here are some recent targets:

  • Jason Kolbert from D. Boral Capital set a target price of $10.0 on 04/28/2025
  • Yi Chen from HC Wainwright & Co. set a target price of $1.0 on 03/28/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles